Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced the U.S. Food and Drug Administration accepted its supplemental Biologics License Application for Ziihera ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA